|
CN112203583A
|
|
Blood-expelling auxiliary device and blood-expelling belt
|
|
CA3075867A1
|
|
Anti-ramp2 antibody
|
|
WO2016135772A1
|
|
Method for diagnosing, preventing and treating cancer brain metastasis, and drug delivery system for enabling passage through blood-brain barrier
|
|
AU2012277185A1
|
|
Soluble integrin alpha4 mutant
|
|
AU2010299017A1
|
|
Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
|
|
CA2754591A1
|
|
Generation, expression and characterization of the humanized k33n monoclonal antibody
|
|
CN102027013A
|
|
Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
|
|
US2011318368A1
|
|
Anti-human α9 integrin antibody and use thereof
|
|
KR20100100962A
|
|
HUMANIZED ANTI-α9 INTEGRIN ANTIBODIES AND THE USES THEREOF
|
|
CA2726885A1
|
|
Sirna of human osteopontin
|
|
CN101528777A
|
|
Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
|
|
KR20090039744A
|
|
ANTIHUMAN alpha;9 INTEGRIN ANTIBODY AND USE OF THE SAME
|
|
EP1840135A1
|
|
Anti-alhpha 9 integrin antibody and the use thereof
|
|
WO2005100562A1
|
|
OSTEOPONTIN siRNA
|
